Jasper Therapeutics, Inc.

NASDAQ (USD): Jasper Therapeutics, Inc. (JSPR)

Last Price

6.32

Today's Change

+0.11 (1.77%)

Day's Change

6.04 - 6.48

Trading Volume

402,179

Overview

Market Cap

94 Million

Shares Outstanding

15 Million

Avg Volume

477,275

Avg Price (50 Days)

16.41

Avg Price (200 Days)

19.83

PE Ratio

-1.33

EPS

-4.75

Earnings Announcement

03-Mar-2025

Previous Close

6.21

Open

6.25

Day's Range

6.04 - 6.48

Year Range

5.25 - 31.01

Trading Volume

402,179

Price Change Highlight

1 Day Change

1.77%

5 Day Change

7.85%

1 Month Change

-67.20%

3 Month Change

-71.31%

6 Month Change

-62.43%

Ytd Change

-70.03%

1 Year Change

-51.20%

3 Year Change

-86.92%

5 Year Change

-93.60%

10 Year Change

-93.56%

Max Change

-93.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment